TNFRSF10D (TNF receptor superfamily member 10d)

2003-06-01  

Identity

HGNC
LOCATION
8p21.3
LOCUSID
ALIAS
CD264,DCR2,TRAIL-R4,TRAILR4,TRUNDD

Other Information

Locus ID:

NCBI: 8793
MIM: 603614
HGNC: 11907
Ensembl: ENSG00000173530

Variants:

dbSNP: 8793
ClinVar: 8793
TCGA: ENSG00000173530
COSMIC: TNFRSF10D

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000173530ENST00000312584Q9UBN6

Expression (GTEx)

0
10
20
30
40
50
60
70
80

Pathways

PathwaySourceExternal ID
Cytokine-cytokine receptor interactionKEGGko04060
ApoptosisKEGGko04210
Natural killer cell mediated cytotoxicityKEGGko04650
Cytokine-cytokine receptor interactionKEGGhsa04060
ApoptosisKEGGhsa04210
Natural killer cell mediated cytotoxicityKEGGhsa04650
MeaslesKEGGko05162
MeaslesKEGGhsa05162
Influenza AKEGGko05164
Influenza AKEGGhsa05164
HemostasisREACTOMER-HSA-109582
Cell surface interactions at the vascular wallREACTOMER-HSA-202733
Gene ExpressionREACTOMER-HSA-74160
Generic Transcription PathwayREACTOMER-HSA-212436
Transcriptional Regulation by TP53REACTOMER-HSA-3700989
TP53 Regulates Transcription of Cell Death GenesREACTOMER-HSA-5633008
TP53 Regulates Transcription of Death Receptors and LigandsREACTOMER-HSA-6803211

References

Pubmed IDYearTitleCitations
316129902020Survival of aging CD264(+) and CD264(-) populations of human bone marrow mesenchymal stem cells is independent of colony-forming efficiency.7
316129902020Survival of aging CD264(+) and CD264(-) populations of human bone marrow mesenchymal stem cells is independent of colony-forming efficiency.7
311835062019Heterogeneous intracellular TRAIL-receptor distribution predicts poor outcome in breast cancer patients.8
311835062019Heterogeneous intracellular TRAIL-receptor distribution predicts poor outcome in breast cancer patients.8
298794212018High-dose HOOK effect in urinary DcR2 assay in patients with chronic kidney disease.1
298794212018High-dose HOOK effect in urinary DcR2 assay in patients with chronic kidney disease.1
283562932017Urinary DcR2 is a novel biomarker for tubulointerstitial injury in patients with diabetic nephropathy.7
289625882017Decoy TRAIL receptor CD264: a cell surface marker of cellular aging for human bone marrow-derived mesenchymal stem cells.20
283562932017Urinary DcR2 is a novel biomarker for tubulointerstitial injury in patients with diabetic nephropathy.7
289625882017Decoy TRAIL receptor CD264: a cell surface marker of cellular aging for human bone marrow-derived mesenchymal stem cells.20
260506212016Decoy receptors block TRAIL sensitivity at a supracellular level: the role of stromal cells in controlling tumour TRAIL sensitivity.32
265427572016Epigenetic inactivation of TRAIL decoy receptors at 8p12-21.3 commonly deleted region confers sensitivity to Apo2L/trail-Cisplatin combination therapy in cervical cancer.11
260506212016Decoy receptors block TRAIL sensitivity at a supracellular level: the role of stromal cells in controlling tumour TRAIL sensitivity.32
265427572016Epigenetic inactivation of TRAIL decoy receptors at 8p12-21.3 commonly deleted region confers sensitivity to Apo2L/trail-Cisplatin combination therapy in cervical cancer.11
246498042014Membrane expression of trail receptors DcR1 and DcR2 in the normal endometrium, endometrial atypical hyperplasia and endometrioid endometrial cancer.0

Citation

Dessen P

TNFRSF10D (TNF receptor superfamily member 10d)

Atlas Genet Cytogenet Oncol Haematol. 2003-06-01

Online version: http://atlasgeneticsoncology.org/gene/42608/favicon/apple-touch-icon.png